Hyperhomocysteinemia plays a role in the progression of myocardial hypertrophy by the formation of the MEF2C-HDAC1 (myocyte-specific enhancer factor 2C/histone deacetylases) complex. Here, MEF2C is linked to hyperhomocysteinemia.